Gangat Naseema, Tefferi Ayalew
Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
Am J Hematol. 2025 Aug;100(8):1271-1276. doi: 10.1002/ajh.27730. Epub 2025 May 29.
CPX-351 has similar efficacy but more toxicity compared to venetoclax+hypomethylating agent therapy.